Market Outline: Apheresis Market
Apheresis also referred as pheresis or hem apheresis. Apheresis is process of widrawel of the blood from the donors or patients body and removal one or more blood components such as platelets, plasma or WBC. Components are separated using the technologies such as centrifugation or membrane filter.
Market Dynamics: Apheresis Market
Global apheresis market is primarily driven by the rise in the blood donations around the world due to the increase in awareness and various camps conducted by the government and non-government organizations. In addition, apheresis procedure also used in treatment of the various neurological, renal, autoimmune and cardiovascular diseases. Furthermore, rise in demand for blood components to treat the various conditions around the world and expansion of application of apheresis procedure to different treatments projected to boost the market growth over the forecast period. However, the complications associated with the apheresis procedure and dearth of skilled professionals expected to hamper the market growth during the forecast period.
Market Scope: Apheresis Market
Ocular drug delivery technology market is segmented based on product, application, procedure, technology and end user
Based on product, the market is segmented into the following:
Based on application, the market is segmented into following:
- Renal Disorders
- Auto immune Diseases
Based on procedure, the market is segmented into following:
- LDL Pheresis
Based on Technology, the market is segmented into following:
- Membrane Filtration
Based on end user, the market is segmented into the following:
- Ambulatory Surgical Centers
- Blood Collection Centers
Market Summary: Apheresis Market
Global apheresis market expected to witness significant growth rate over the forecast period owing to the raise in the support from the government and non-government organizations in donation of the blood. According to the statistics of World Health Organization (WHO), there were 112.5 million blood donations were collected globally in 2013, and about half of the donations are from the developed countries such as Canada and United States. Market players focus on development of the advanced automated apheresis devices to improve the position in the market. Furthermore, acquisitions and mergers also key strategies adopted to expand their market share. In procedure segment plasmapheresis projected to have the significant growth rate owing to the escalating number of procedures.
Regional Analysis: Apheresis Market
Geographically, global medical gas analyzers market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America apheresis market expected to have largest share owing to the established healthcare infrastructure, well awared population and growing number of blood donations in the region. Asia Pacific apheresis market projected to have the highest growth rate owing to rapid development in healthcare infrastructure and growing demand for the blood components for the patients. Furthermore, upsurge in number of blood donation in developing countries such as India and China projected to boost the market share over the forecast period. Europe apheresis market is expected to have the significant growth rate due to the increase in number of hospitals and growing awareness related to blood donation and demand for the blood components.
- Fresenius Medical Care (Germany)
- Haemonetics Corporation (U.S.)
- Asahi Kasei Medical Co., Ltd. (Japan)
- Terumo BCT, Inc. (U.S.)
- Cerus Corporation (U.S.)
- Kawasumi Laboratories Inc. (Japan)
- Kaneka Corporation (Japan)
- HemaCare Corporation (U.S.)
- Braun Melsungen AG (Germany)
- Nikkiso Co., Ltd. (Japan)
Notable Market Developments:
- In May 2014, Terumo BCT inked a business relationship agreement with Kaneka Corporation to gain the market authorization for Terumo BCT Spectra Optia Apheresis System with Kaneka Liposorber-LA-40s LDL Adsorption Coloumn in U.S. for treating the patients with high cholesterol